Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $4.82 | Change: $-0.18 | %Change: -3.60%
Volume: 99,271 | Day High/Low: 5.09/4.45 | 52 Week High/Low: 5.73/1.58
View modes: 
3.5 stars

RE:RE:So what do I know?

So TheRock07 just turned into a Lil rock07 with his astounding comment.  rate and reply
2.5 stars

RE:So what do I know?

You' re not a shareholder so who cares what a dolt like you thinks. Get lost.  rate and reply
4.5 stars

So what do I know?

When I first heard about the settlement in an e-mail from a p*ssed investor, one of many as it turns out, I felt the tightening in my stomach as I raced to read the PR. Management had once again...read more
2.5 stars

Lil Folk Active Again

Recent Trades - Last 10 of 108 Time ET Ex Price Change Volume Buyer Seller   15:53:38 T 3...read more
4 stars

RE:RE:RE:RE:Mally Concedes...$10 million US cash plus all US rights to P

is that $10 million after the lawyers take their cut, or before?  rate and reply
3 stars

RE:RE:RE:Mally Concedes...$10 million US cash plus all US rights to P

Who wants to guess how long a new partner might take to find ? And then prime their distribution channels and their boots on the ground. That is likely months of dead sales, if not a year,  which is...read more
5 stars

RE:RE:Mally Concedes...$10 million US cash plus all US rights to P

NRI has to sign another partner and then transition distribution to it I would imagine. After that is complete all rights go to NRI plus the $10 million.  rate and reply
0 stars

RE:Mally Concedes...$10 million US cash plus all US rights to P

"Under the terms of the settlement agreement, Mallinckrodt will return all U.S. rights to Pennsaid and Pennsaid 2 per cent to Nuvo after a brief transition period and pay $10-million (U.S.). " Is it...read more
5 stars

RE:$20 Million in Cash..$2 per share

What will the upfront money from the new deal be worth? Will they soon have $30 million cash or $3 per share?  rate and reply
3 stars

Investment Conference Presentation Tommorow

The presentation is not yet on the NRI website but should be there tommrow... The presentation at the Rodman & Renshaw Global Investment Conference on Tuesday, September 9, 2014 should enclude...read more
5 stars

RE:$20 Million in Cash..$2 per share

$60 million? If Nuvo were to offer to sell only the full US rights to Pennsaid for $60 million, somebody would find a way to get them that cash by the end of the day.  rate and reply
3 stars

$20 Million in Cash..$2 per share

It wont take them long to attract a new JV partner for P2. They now have plenty of dough to see them thru for the next 2 years......if they are not taken out by then. Someone..perhaps GUD...will now...read more
3 stars

RE:they only get 10 million

That's nothing - what about their bonuses for cutting such a great deal LOL?  rate and reply
3 stars

RE:10 mil

With no phase 3, The Pennsaid USA franchise is made up of two approved drugs on their way to pulling down more than $50 million earnings annually. That is a ridiculously large asset for a company with...read more
0 stars

10 mil

Not near enough to complete phase 3 though unless new partner is willing.  rate and reply
1 star

RE:RE:they only get 10 million

It may be poor compensation for the lost opportunity, but it's a dollar per share in cash. It puts the issue to rest and gives us the tools to go forward. I'm good with it.  rate and reply
1 star

RE:they only get 10 million

If you really believe the cash is the biggest part of this settlement, I suggest you may want to consider steering clear of the pharmaceutical sector when picking stocks.  rate and reply
1 star

RE:Mally Concedes...$10 million US cash plus all US rights to P

It was pretty obvious that NRI had a solid case which, after discovery, became obvious to Mally. So, we get a $10 million US cash settlement plus the full return to all rights to P and P2. This was...read more
0 stars

Mally Concedes...$10 million US cash plus all US rights to P

UVO RESEARCH SETTLES LITIGATION WITH MALLINCKRODT PHARMACEUTICALS Nuvo Research Inc. has reached a full settlement with Mallinckrodt Inc. of Nuvo's claims and Mallinckrodt's counterclaim relating to...read more
0 stars

they only get 10 million

I wonder what the legal bill will be  rate and reply

How to invest in private equity without writing a $1 million check.

Click here to watch the video